Inactive Instrument

Other languages Metacrine, Inc.

Equities

Metacrine, Inc. Announces Board Changes	24/23/24
Metacrine, Inc. Announces CEO Changes	24/23/24
Metacrine, Inc. Appoints Michael York as President	04/23/04
Metacrine, Inc. Appoints Michael York as Chief Executive Officer	04/23/04
Insider Sell: Metacrine	28/23/28
Equillium, Inc. (NasdaqGM:EQ) cancelled the acquisition of Metacrine, Inc. from a group of shareholders.	23/22/23
Insider Buy: Metacrine	22/22/22
Metacrine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15
Insider Buy: Metacrine	31/22/31
Metacrine, Inc. Enters into A License Agreement with FL2022-001, Inc	12/22/12
Equillium to Acquire Biopharmaceutical Company Metacrine in All-Stock Deal	07/22/07
Metacrine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/22/10
Metacrine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13
Metacrine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31
Metacrine, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	31/22/31
Metacrine, Inc. Enters into an Agreement for Termination of Lease	16/22/16
Metacrine, Inc. Promotes Michael York as Chief Business Officer	25/22/25
Metacrine, Inc. Announces Board Changes	11/22/11
Metacrine, Inc. Remains on Track to Begin A Phase 2 Clinical Trial in Ulcerative Colitis	11/22/11
Metacrine to Cut 50% of Workforce Amid Restructuring; Shares Cllimb	11/22/11

No results for this search